Terms: = Skin cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
75 results:
1. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of skin cancer.
Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
[TBL] [Abstract] [Full Text] [Related]
2. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Weber JS; Carlino MS; Khattak A; Meniawy T; Ansstas G; Taylor MH; Kim KB; McKean M; Long GV; Sullivan RJ; Faries M; Tran TT; Cowey CL; Pecora A; Shaheen M; Segar J; Medina T; Atkinson V; Gibney GT; Luke JJ; Thomas S; Buchbinder EI; Healy JA; Huang M; Morrissey M; Feldman I; Sehgal V; Robert-Tissot C; Hou P; Zhu L; Brown M; Aanur P; Meehan RS; Zaks T
Lancet; 2024 Feb; 403(10427):632-644. PubMed ID: 38246194
[TBL] [Abstract] [Full Text] [Related]
3. The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis.
Zarin B; Nedaeinia R; Laher I; Manian M; Javanmard SH
Tumour Biol; 2023; 45(1):111-126. PubMed ID: 37927290
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxic microenvironment promotes dermal fibroblast migration and proliferation via a BNIP3-autophagy pathway.
Zhang C; Li H; Jiang M; Zhang Q; Chen J; Jia J; Zhang Z; Yu H; Zhang J; Zhang J
FEBS J; 2024 Jan; 291(2):358-375. PubMed ID: 37873601
[TBL] [Abstract] [Full Text] [Related]
5. IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas.
Martin-Morales N; Padial-Molina M; Tovar I; De Araujo Farias V; Hernández-Cortés P; Ramirez-Moreno E; Caba-Molina M; Davis J; Carrero Castaño A; Ruiz de Almodovar JM; Galindo-Moreno P; Oliver-Pozo J; O'Valle Ravassa FJ
Pathobiology; 2024; 91(2):132-143. PubMed ID: 37797584
[TBL] [Abstract] [Full Text] [Related]
6. Functional Involvement of ADRA1D in Cutaneous Melanoma Progression and Angiogenesis.
Wang J; Ning D; Xie D; Chen X; Cao X; Wan C
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):44-50. PubMed ID: 37571902
[TBL] [Abstract] [Full Text] [Related]
7. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.
Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI
Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772
[TBL] [Abstract] [Full Text] [Related]
8. TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-
Zhao B; Niu X; Huang S; Yang J; Wei Y; Wang X; Wang J; Wang Y; Guo X
Anal Cell Pathol (Amst); 2022; 2022():4201262. PubMed ID: 35464826
[TBL] [Abstract] [Full Text] [Related]
9. 2-Methoxyestradiol Inhibits Radiation-Induced skin Injuries.
Kim JH; Nam JK; Kim AR; Park MS; Lee HJ; Park J; Kim J; Lee YJ
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456989
[TBL] [Abstract] [Full Text] [Related]
10. Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy.
Liu Y; Xu D; Liu Y; Zheng X; Zang J; Ye W; Zhao Y; He R; Ruan S; Zhang T; Dong H; Li Y; Li Y
Biomaterials; 2022 May; 284():121516. PubMed ID: 35436740
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo.
Niessner H; Burkard M; Leischner C; Renner O; Plöger S; Meraz-Torres F; Böcker M; Hirn C; Lauer UM; Venturelli S; Busch C; Sinnberg T
Cells; 2022 Apr; 11(7):. PubMed ID: 35406796
[TBL] [Abstract] [Full Text] [Related]
12. Single cell transcriptomic landscape of diabetic foot ulcers.
Theocharidis G; Thomas BE; Sarkar D; Mumme HL; Pilcher WJR; Dwivedi B; Sandoval-Schaefer T; Sîrbulescu RF; Kafanas A; Mezghani I; Wang P; Lobao A; Vlachos IS; Dash B; Hsia HC; Horsley V; Bhasin SS; Veves A; Bhasin M
Nat Commun; 2022 Jan; 13(1):181. PubMed ID: 35013299
[TBL] [Abstract] [Full Text] [Related]
13. The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma.
Malekan M; Ebrahimzadeh MA; Sheida F
Biomed Pharmacother; 2021 Sep; 141():111873. PubMed ID: 34225012
[TBL] [Abstract] [Full Text] [Related]
14. Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells.
Wang Y; Li Z; Teng M; Liu J
Int J Med Sci; 2021; 18(12):2705-2715. PubMed ID: 34104103
[TBL] [Abstract] [Full Text] [Related]
15. Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma.
Liu Y; He D; Xiao M; Zhu Y; Zhou J; Cao K
Cell Death Dis; 2021 Mar; 12(3):245. PubMed ID: 33664256
[TBL] [Abstract] [Full Text] [Related]
16. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.
de Azevedo RA; Shoshan E; Whang S; Markel G; Jaiswal AR; Liu A; Curran MA; Travassos LR; Bar-Eli M
Oncoimmunology; 2020 Dec; 9(1):1846915. PubMed ID: 33344042
[TBL] [Abstract] [Full Text] [Related]
17. Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanoma.
Shimizu T; Nagane M; Suzuki M; Yamauchi A; Kato K; Kawashima N; Nemoto Y; Maruo T; Kawakami Y; Yamashita T
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129723. PubMed ID: 32861756
[TBL] [Abstract] [Full Text] [Related]
18. Anticancer Potential of Aguerin B, a Sesquiterpene Lactone Isolated from
Amini E; Nabiuni M; Behzad SB; Seyfi D; Eisvand F; Sahebkar A; Shakeri A
Recent Pat Anticancer Drug Discov; 2020; 15(2):165-173. PubMed ID: 32660408
[TBL] [Abstract] [Full Text] [Related]
19. Hypoxia factors suppression effect on the energy metabolism of a malignant melanoma cell SK-MEL-30.
Špaková I; Graier WF; Rabajdová M; Dubayová K; Nagyová V; Mareková M
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4909-4920. PubMed ID: 32432754
[TBL] [Abstract] [Full Text] [Related]
20. Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.
Dmitrieva NI; Walts AD; Nguyen DP; Grubb A; Zhang X; Wang X; Ping X; Jin H; Yu Z; Yu ZX; Yang D; Schwartzbeck R; Dalgard CL; Kozel BA; Levin MD; Knutsen RH; Liu D; Milner JD; López DB; O'Connell MP; Lee CR; Myles IA; Hsu AP; Freeman AF; Holland SM; Chen G; Boehm M
J Clin Invest; 2020 Aug; 130(8):4167-4181. PubMed ID: 32369445
[TBL] [Abstract] [Full Text] [Related]
[Next]
